“A great idea is a great idea, no matter where it comes from.”
The Corporate Business Development function, formerly known as Pharma Partnering, manages the entire business development spectrum, from identifying new partnering opportunities to executing deals and managing global alliances and assets.
In 2009, Genentech became a member of the Roche group and the headquarters for Roche pharmaceutical operations in the United States. In 2018, Roche Partnering and Genentech Partnering merged into one global team that provides comprehensive business development and alliance management support for Roche and Genentech. Genentech maintains its own independent Research & Early Development group (gRED), allowing scientists to work freely, think and address problems in unique ways, and enhance innovation.
-
>250 active global partnerships supporting innovation, research, and long-term growth
-
16 of 21 new medicines have involved a partner over the last decade
-
140 people worldwide focused on bringing in and managing lasting partnerships
Our approach
Our success in bringing breakthrough treatments to patients today is the result of pioneering partnerships that are built on trust, flexibility, shared values and a passion for advancing science to make a lasting contribution for people’s health.
Where We Are
With about 140 colleagues around the globe, we are building the bridge between brilliant ideas coming from within Genentech and Roche and those coming from the world around us. Our global footprint with offices in Basel, South San Francisco, Boston, Cambridge, Shanghai, Seoul and Tokyo offers speed, flexibility and accessibility.
South San Francisco
Keep discovering below
What Makes Genentech a unique partner for you
At Genentech and Roche, our unique company structure and culture allow us to foster meaningful, long-lasting partnerships that transform groundbreaking science into life-changing advancements for patients. We are committed to transparent collaboration, creating a dynamic ecosystem where innovation thrives. As a trusted partner, we focus on mutual growth and success, driven by a shared vision of making a positive impact on society.
Three facts that make us a unique pharma partner:
- Unique structure
- As the only company to combine R&D, innovative pharmaceuticals, diagnostics, and technology under one roof, Roche and Genentech can support patients from diagnosis to treatment.
- Innovation is our lifeblood
- We have a proven history of major scientific breakthroughs. Our global network of scientific talent, spread across autonomous R&D units, tackles healthcare challenges from different angles, often hand in hand with partners.
- Collaboration is in our DNA
- Partnerships are at the core of how we invent, discover, and develop new medicines. Working with a partner like Roche and Genentech offers smaller biotech companies additional financial stability and scientific expertise.
Our capabilities strongly position us to deliver on our ambition
